Randomized Phase 3 study of Eryaspase in combination with either Gemcitibine/ Abraxane or FOLFIRI compared with Gemcitibine/ Abraxane or FOLFIRI alone as second line therapy in patients with stage III/IV pancreatic cancer

Type of Cancer
Pancreatic

Site
Bethesda

Protocol Number
Pancreatic Cancer

To Learn More Call
(201)-510-0950